COMT polymorphism as a genetic factor in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease
Objective: We examined the influence of single nucleotide polymorphisms (SNPs) in specific genes on levodopa-induced dyskinesia development in Parkinson’s disease patients Background: Levodopa-induced dyskinesia (LID)…JourneyMap: A visual resource to reduce coordinator burden during virtual study visits
Objective: Reduce burden on research team members and study participants during remote deployment of a touchless sensor device for in-home use with people with Parkinson’s…Virtual Visit Experience of the Portland Oregon Pacific UDALL Center During COVID-19
Objective: To retain a well-characterized longitudinal Parkinson’s Study, The Portland Oregon Pacific UDALL Center (PRE-PUC) cohort, during the pandemic years. Background: Although best known for…Environmental exposures and clinical phenotype in a sample of patients with Parkinson’s disease in the southwestern Colombian region: preliminary results
Objective: Describe the clinical phenotype and environmental agents of patients from the Colombian southwestern region with familiar and sporadic Parkinson’s disease in a sample Background:…Alteration of the fecal microbiota in Turkish patients with idiopathic Parkinson’s disease
Objective: To determine whether the gut microbiota is altered in Turkish patients with Parkinson Disease (PD) and the potential effect of gut microbiota on pre-motor…IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions
Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…Glial neurotrophic factor as an early diagnostic marker in Parkinson’s disease
Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) Background: Glial neutrophic factor (GDNF) is a…Shared molecular genetic factors influence brain morphometry and Parkinson’s disease risk
Objective: To explore the genetic overlap and identify shared genomic regions between brain morphometry and Parkinson’s disease (PD) risk. Background: PD is a genetically complex…A randomized, double-blinded crossover trial of short versus conventional pulse width subthalamic deep brain stimulation in Parkinson’s Disease
Objective: To compare 4 weeks of STN-DBS with conventional pulse width stimulation (60µs) to 4 weeks of STN-DBS with short pulse width stimulation (30µs) regarding…Effectiveness of Combined tDCS and tNIRS on Motor Performance in Parkinson’s Disease – A Single Case Study
Objective: The aim of the current study was to evaluate the synergistic effects of combining transcranial near infrared light stimulation (tNIRS) and transcranial direct current stimulation…
- « Previous Page
- 1
- …
- 357
- 358
- 359
- 360
- 361
- …
- 436
- Next Page »